利润表
ABEONA THERAPEUTICS INC.
ABEO
业绩概览
点击表格中任意一行将其添加到图表
单位：百万美元
| 指标 | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Dec 31, 2014 2014 FY | Dec 31, 2013 2013 FY | Dec 31, 2012 2012 FY | Dec 31, 2011 2011 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
营业收入
|
5.82 | 0.00 | 3.50 | 1.41 | 3.00 | 10.00 | - | 3.00 | 0.84 | 0.89 | 1.04 | 0.93 | 2.04 | 4.40 | 1.85 |
|
营业成本
|
1.53 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
毛利润
|
4.29 | - | 3.50 | 1.41 | 3.00 | 10.00 | - | 3.00 | 0.84 | 0.89 | 1.04 | 0.93 | 2.04 | 4.40 | 1.85 |
|
营业费用
|
91.84 | 64.21 | 50.64 | 52.33 | 92.84 | 91.42 | 77.09 | 58.80 | 27.93 | 23.95 | 19.04 | 4.05 | 5.72 | 8.03 | 8.28 |
|
研发费用
|
26.81 | 34.36 | 31.09 | 28.97 | 34.33 | 30.14 | 48.57 | 38.70 | 16.99 | 10.66 | 4.72 | 0.33 | 0.88 | 2.01 | 4.20 |
|
销售、一般及行政费用
|
65.03 | 29.85 | 19.00 | 17.26 | 22.80 | 23.78 | 20.71 | 20.11 | 10.94 | 13.29 | 14.32 | 3.71 | 4.83 | 6.02 | 4.08 |
|
其他营业费用
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
营业利润
|
-87.56 | -64.21 | -47.14 | -50.92 | -89.84 | -81.42 | -77.09 | -55.81 | -27.10 | -23.06 | -18.00 | -3.12 | -3.68 | -3.63 | -6.43 |
|
营业外收入
|
0.41 | 1.19 | 2.94 | - | - | - | - | - | 0.52 | 2.01 | 4.02 | -23.65 | 8.25 | -6.22 | 5.36 |
|
利息收入
|
5.56 | 4.25 | 2.12 | 0.43 | - | - | - | - | - | - | - | - | - | - | - |
|
利息支出
|
3.74 | 4.21 | 0.42 | 0.74 | 3.67 | - | - | - | - | - | - | - | - | - | - |
|
其他营业外收入/支出
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
税前利润
|
71.28 | - | - | - | - | - | - | - | - | - | - | - | - | -10.53 | -2.52 |
|
所得税费用
|
0.10 | - | - | - | - | - | - | - | - | - | - | - | - | -10.53 | -2.52 |
|
少数股东损益
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
净利润
|
71.18 | -63.73 | 65.88 | 50.35 | -84.94 | -84.23 | -76.28 | -56.67 | -27.32 | -21.87 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
补充资料
每股数据、派生项目及其他——不属于利润表
除特别注明外，单位均为百万美元
| 指标 | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Dec 31, 2014 2014 FY | Dec 31, 2013 2013 FY | Dec 31, 2012 2012 FY | Dec 31, 2011 2011 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
折旧与摊销
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
EBITDA
|
-85.01 | -62.21 | -44.85 | -47.82 | -86.59 | -76.83 | -69.27 | -53.45 | -26.35 | -22.23 | -17.44 | -3.11 | -3.67 | -3.21 | -6.19 |
|
基本每股收益
|
1.34 | -1.55 | -2.53 | -5.53 | - | - | - | - | - | - | - | -15.26 | 0.06 | - | - |
|
稀释每股收益
|
1.01 | -1.55 | -2.53 | - | - | - | - | - | - | - | - | -15.26 | 0.06 | - | - |
|
加权平均股数
|
52.95 | 41.05 | 21.38 | 7.86 | - | - | - | - | - | 34.18 | 27.60 | 1.94 | 25.24 | - | - |
|
稀释加权平均股数
|
66.14 | 41.05 | 21.38 | - | - | - | - | - | - | - | - | 1.94 | 25.47 | - | - |
|
综合收益
|
71.31 | -63.66 | -54.13 | -43.58 | -84.95 | -84.24 | - | - | - | - | - | - | - | - | - |